Considering the clinical and laboratory context, along with the patient’s prior history of ICI therapy, the diagnosis of ICI-induced thyroiditis was established, initially manifesting as thyroiditis (hashitoxicosis) due to the release of thyroid hormones from the inflamed thyroid gland. Here, TG is linked to thyroid gland disorder.